Anteris Technologies Ltd.
Clinical trials sponsored by Anteris Technologies Ltd., explained in plain language.
-
New heart valve device tested in humans for first time
Disease control OngoingThis study tests a new device called the DurAVR™ THV System, a replacement heart valve placed through a small tube in an artery, for people with severe aortic stenosis (a narrowed heart valve). The trial involves 150 participants and aims to see if the device is safe and works we…
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New heart valve shows promise in early trial for aortic stenosis
Disease control OngoingThis early study tests a new device called the DurAVR™ heart valve in 15 people aged 65 and older with severe aortic stenosis, a condition where the heart's aortic valve becomes narrowed. The valve is implanted through a catheter (TAVR) without open-heart surgery. The main goals …
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New heart valve device shows early promise in small study
Disease control OngoingThis early study is testing a new device called the DurAVR™ THV System, which is a replacement heart valve placed through a small tube in the leg (TAVI procedure). The study includes 40 people with severe aortic stenosis or a failed surgical valve. The main goal is to see if the …
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC